Lobbying

Neurofibromatosis, Inc., Northeast's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Budget/Appropriations and Defense.

Neurofibromatosis, Inc., Northeast

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Neurofibromatosis, Inc., Northeast lobbying by quarter
Neurofibromatosis, Inc., Northeast lobbying by quarter
QuarterAmountReports
Q4 2022$10K1
Q1 2023$10K1
Q2 2023$10K1
Q3 2023$10K1
Q4 2023$10K1
Q1 2024$10K1
Q2 2024$10K1
Q3 2024$10K1
Q4 2024$10K1
Q1 2025$01
Q2 2025$01
Q3 2025$01
Q4 2025$01
Q1 2026$01
Q2 2026$01
Q3 2026$00

By issue

  • Budget and appropriations$45K · 15 reports
  • Defense$45K · 15 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES13 reports
  • SENATE13 reports
  • Army, Dept of (Other)1 reports

Firms it paid

Firm
Van Scoyoc Associates$90K15 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
07/17for Q2Van Scoyoc AssociatesUnder $5,000
04/17for Q1Van Scoyoc AssociatesUnder $5,000
01/19for Q4 2025Van Scoyoc AssociatesUnder $5,000
25/10/17for Q3 2025Van Scoyoc AssociatesUnder $5,000
25/07/18for Q2 2025Van Scoyoc AssociatesUnder $5,000
25/04/18for Q1 2025Van Scoyoc AssociatesUnder $5,000
25/01/20for Q4 2024Van Scoyoc Associates$10K
24/10/18for Q3 2024Van Scoyoc Associates$10K
24/07/19for Q2 2024Van Scoyoc Associates$10K
24/04/19for Q1 2024Van Scoyoc Associates$10K
24/01/19for Q4 2023Van Scoyoc Associates$10K
23/10/19for Q3 2023Van Scoyoc Associates$10K
23/07/19for Q2 2023Van Scoyoc Associates$10K
23/04/19for Q1 2023Van Scoyoc Associates$10K
23/01/19for Q4 2022Van Scoyoc Associates$10K